Bejcek Alexis, Wenkert David
Department of Medicine, Baylor Scott & White Medical Center - Temple, Temple, Texas.
Division of Endocrinology, Department of Medicine, Baylor Scott & White Medical Center - Temple, Temple, Texas.
Proc (Bayl Univ Med Cent). 2021 Oct 15;35(1):84-85. doi: 10.1080/08998280.2021.1984792. eCollection 2022.
Hemoglobin A1c (HbA1c) is an important tool for diagnosis and management of patients with diabetes mellitus (DM). However, hemoglobin variants can interfere with laboratory assays and lead to inaccurate results. This study describes a patient who was found to have falsely elevated HbA1c values secondary to hemoglobin Wayne, a rare hemoglobin variant. Although hemoglobin Wayne is often clinically silent, falsely elevated HbA1c results could lead to unnecessary medical interventions that could cause patient harm. This variation in results highlights the importance of utilizing additional measurements such as glucose readings and evaluating for hemoglobin variants when results are discordant.
糖化血红蛋白(HbA1c)是诊断和管理糖尿病(DM)患者的重要工具。然而,血红蛋白变异体可干扰实验室检测并导致结果不准确。本研究描述了一名患者,其因罕见的血红蛋白变异体——韦恩血红蛋白,导致糖化血红蛋白值假性升高。尽管韦恩血红蛋白在临床上通常无明显症状,但糖化血红蛋白结果假性升高可能导致不必要的医疗干预,进而对患者造成伤害。结果的这种差异凸显了在结果不一致时利用额外测量(如血糖读数)并评估血红蛋白变异体的重要性。